Michelle Gillice focuses her practice on regulatory compliance and enforcement concerning the US Consumer Product Safety Commission (CPSC) and Drug Enforcement Administration (DEA). Following her tenure at both agencies, she now helps clients find practical solutions that reduce liability risks and protect their brands.

Ms. Gillice counsels manufacturers and retailers on compliance with the Consumer Product Safety Act (CPSA) and its implementing regulations. She regularly advises companies on reporting obligations, avoiding unnecessary recalls, developing effective corrective action plans, penalty investigations and defending enforcement actions. Ms. Gillice has extensive experience in matters involving industry voluntary standards, children’s products, testing and certification, flammable fabrics, child-resistant packaging, and labeling requirements under the Federal Hazardous Substances Act. During her nine years of service at CPSC between 2002 and 2012, Ms. Gillice was the lead attorney on numerous compliance investigations, recalls, and civil penalty matters involving retailers, importers, and manufacturers. Ms. Gillice also served on a detail as legal counsel to CPSC Chairman Inez Tenenbaum, and led an interdisciplinary team on all investigations, compliance activities, and education and outreach related to infant sleep products.

In addition, Ms. Gillice counsels pharmaceutical manufacturers, wholesale distributors, hospitals, and other healthcare clients on regulatory compliance and enforcement issues involving the Controlled Substances Act (CSA) and its implementing regulations. She also advises companies on business procedures relating to DEA registration, recordkeeping, reporting, and security. Immediately prior to joining the firm in 2016, Ms. Gillice served as a senior attorney at DEA, Office of Chief Counsel, Diversion and Regulatory Litigation Section, where she represented the federal government in administrative litigation against wholesale distributors, pharmacies, and practitioners for alleged violations of the CSA.


President Trump to Nominate Dana Baiocco to be CPSC Commissioner, Signaling Shift in Control
Seller Beware: Consumer Protection Insights for Industry
CPSC Reduces Testing Requirements for Phthalates in Children's Toys and Childcare Articles
Seller Beware: Consumer Protection Insights for Industry
Child Resistant Packaging Today Seminar
Perritt Laboratories Symposium, Alexandria, VA
DEA Requirements for the Supply Chain
HDA Distribution Management Conference and Expo, Palm Desert, CA
Update on FDA and DEA Developments


The Legal 500 US
Product Liability and Mass Tort Defense: Pharmaceuticals and Medical Devices (2017)
Product Liability, Mass Tort and Class Action: Consumer Products (including tobacco) (2017)


  • JD, American University Washington College of Law, 1997
  • BS, Syracuse University, 1992, cum laude
  • District of Columbia

Email Disclaimer